Twist Bioscience Corp 2024 SR
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which reduces chemical reagent consumption by 99.8% compared to traditional methods. In fiscal 2023, the company achieved record revenue of $245.1 million and expanded its manufacturing capabilities with the launch of Express Genes. Key environmental achievements include diverting over 24,795 pounds of plastic waste through recycling programs and disclosing Scope 1 and Scope 2 emissions for the first time. The company also emphasizes its diverse workforce, with 42% women and 56% people of color in the U.S., and maintains a robust biosecurity program.
Company: Twist Bioscience Corp
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 63
Twist Bioscience Corp
Corporate Responsibility Report
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which reduces chemical reagent consumption by 99.8% compared to traditional methods. In fiscal 2023, the company achieved record revenue of $245.1 million and expanded its manufacturing capabilities with the launch of Express Genes. Key environmental achievements include diverting over 24,795 pounds of plastic waste through recycling programs and disclosing Scope 1 and Scope 2 emissions for the first time. The company also emphasizes its diverse workforce, with 42% women and 56% people of color in the U.S., and maintains a robust biosecurity program.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Oct 1, 2022 - Sep 30, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Women on Board
Women in Management